粉样蛋白病理,大脑小血管疾病,淋巴功能障碍和认知之间的关系:基于阿尔茨海默病连续参与者的研究
Hui Hong1, Luwei Hong1, Xiao Luo1
1Department of Radiology, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China.
Alzheimer's research & therapy
|February 20, 2024
概括
阿尔茨海默病 (AD) 病理和大脑小血管疾病 (CSVD) 与淋巴功能受损有关,这是痴呆的一个关键因素. 这种功能障碍有助于认知能力下降,这表明了AD的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 老年学是指老年学的学科.
背景情况:
- 淋巴功能障碍是痴呆症发展中的重要途径.
- 阿尔茨海默病 (AD) 病理和大脑小血管疾病 (CSVD) 是痴呆的最常见原因.
- 这项研究调查了AD病理,CSVD和淋巴功能障碍与认知障碍之间的关联.
研究的目的:
- 为了检查阿尔茨海默病 (AD) 病理和脑小血管疾病 (CSVD) 标志物与淋巴功能之间的关系.
- 研究AD连续性个体的淋巴功能标记物和认知表现之间的相关性.
- 探索淋巴体标记物在AD病理/CSVD和认知障碍之间的联系中扮演的调解角色.
主要方法:
- 利用了来自阿尔茨海默病神经成像计划 (ADNI) 的数据,包括粉样蛋白PET,扩散张力成像 (DTI) 和FLAIR序列.
- 评估白质超强度 (WMH) 作为CSVD负担和Aβ通过粉样PET聚合物的标记.
- 使用扩散张力图像分析测量淋巴功能,沿周围血管空间 (DTI-ALPS) 索引,扩大周围血管空间 (PVS) 和胸膜体积.
主要成果:
- 在Aβ聚合和WMH负荷与DTI-ALPS指数之间发现了负相关性.
- 观察到Aβ聚合和WMH负担与胆管体体积之间存在积极的关联.
- DTI-ALPS指数与认知功能 (记忆,执行功能,视觉空间,语言) 有积极的相关性,而胆脉体积则显示出负相关性. DTI-ALPS调解了WMH负担/Aβ积累和认知表现之间的关系.
结论:
- 无论是AD病理还是CSVD都与淋巴功能受损有关.
- 在AD和CSVD的背景下,淋巴功能障碍与认知障碍有关.
- 这些发现表明,通过解决淋巴管功能障碍,可以为阿尔茨海默病提供潜在的新治疗点.
相关概念视频
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Amyloid Fibrils
5.1K
5.1K
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Cognitive Development During Adulthood
109
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
109


